-
Subscribe
for Free
-
-
Our
Cities▾
-
Tech
Channels ▾
-
Meet the
Xconomists ▾
-
Chair, Dept. of Cellular and Molecular Pharmacology, UCSF
-
Co-Founder and CEO, Cascadia Capital
-
Instructor in Pediatrics, Harvard Medical School
-
President and CEO, VLST Corporation
-
Meet All the Xconomists ›
-
Co-Founder and CEO, Modumental
-
Chairman and CEO, Accelerator
-
Partner, Emerging Companies and Life Sciences, Cooley LLP
-
Visiting Scholar, MIT
-
Our
Events ▾
-
|
|
|
|
Archives
|
Entry
|
Author
|
Date
|
Location
|
|
The Greater Boston Diabetes Cluster
|
Ryan McBride |
02/09/09 |
Boston
|
|
Broad Institute Scientists’ Forma Therapeutics Raises $25M, Aims to Knock Out Underpinnings of Cancer
|
Ryan McBride |
01/06/09 |
Boston
|
|
Economy Makes Disease Foundations Get Choosier
|
Ryan McBride |
12/15/08 |
Boston
|
|
Resolvyx Closes in on Clinical Trials, Radius Health Reels in $15M, Luke Zeros in on Public Biotechs’ Bottom Line, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
11/26/08 |
Boston
|
|
Biotech Survival Index: Boston Life Sciences Companies Brace for Long, Hard Winter
|
Luke Timmerman |
11/25/08 |
Boston
|
|
Reported Job Cuts at NameMedia, WSI Add to Week’s Total
|
Wade Roush |
11/21/08 |
Boston
|
|
CombinatoRx Cuts 30 More Jobs, Wiping out Two-Thirds of Staff in Last Month
|
Luke Timmerman |
11/20/08 |
Boston
|
|
CombinatoRx Cuts 45 Percent of Staff After Arthritis Drug Failure
|
Luke Timmerman |
11/04/08 |
Boston
|
|
No Appeal for Boston Scientific, No Luck for CombinatoRx Drug, No Complaints From Harvard, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
10/08/08 |
Boston
|
|
CombinatoRx Reckoning Arrives: Stock Crashes on Failed Arthritis Trial
|
Luke Timmerman |
10/06/08 |
Boston
|
|
Link Makes $40M Connection, Concert and Indevus Launch Clinicals, Genzyme’s Big Cholesterol Strategy, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
10/01/08 |
Boston
|
|
CombinatoRx Judgment Day Coming Soon, Arthritis Drug Results On the Way
|
Luke Timmerman |
09/30/08 |
Boston
|
|
Cortria Hires CEO Grau To Develop Heart Drugs That Won’t Make You Red in the Face
|
Luke Timmerman |
07/16/08 |
Boston
|
|
Will CombinatoRx Be the Next Cambridge Biotech Put on the Block?
|
Rebecca Zacks |
06/18/08 |
Boston
|
|
Take Two Blueberry Jelly Beans and Call Me in the Morning: Cambridge Biotech’s Best and Brightest on Show (or Not)
|
Erik Mellgren |
05/02/08 |
Boston
|
|
In Latest Local Venture Philanthropy Deal, Cystic Fibrosis Foundation Pledges up to $37.7 More to Epix
|
Rebecca Zacks |
04/07/08 |
Boston
|
|
Harvard Launches New Biomedical Fund Round—Hires CombinatoRx Co-Founder to Help Run Effort
|
Robert Buderi |
02/08/08 |
Boston
|
|
Hologic Faces Lawsuit, OLPC Chooses a Distributor, Point Therapeutics Agrees to a Reverse Merger, and More
|
Rebecca Zacks |
10/15/07 |
Boston
|
|
Page 2 of
2 |
« previous page |
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.
© 2007-2012, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Site produced by Andrew Koyfman with design from Rob Hunter.